1776 Wealth LLC Has $479,000 Stake in Danaher Co. (NYSE:DHR)

1776 Wealth LLC trimmed its holdings in Danaher Co. (NYSE:DHR) by 5.7% in the third quarter, Holdings Channel reports. The institutional investor owned 1,723 shares of the conglomerate’s stock after selling 104 shares during the period. 1776 Wealth LLC’s holdings in Danaher were worth $479,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher in the second quarter valued at approximately $25,000. nVerses Capital LLC acquired a new position in Danaher during the second quarter valued at approximately $25,000. MFA Wealth Advisors LLC acquired a new position in Danaher during the second quarter valued at approximately $51,000. Financial Connections Group Inc. acquired a new position in Danaher during the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in Danaher during the first quarter valued at approximately $55,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 3.7 %

Shares of DHR traded down $8.88 on Friday, reaching $230.50. The company’s stock had a trading volume of 5,435,775 shares, compared to its average volume of 2,760,084. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $166.49 billion, a PE ratio of 43.99, a PEG ratio of 4.44 and a beta of 0.85. Danaher Co. has a twelve month low of $206.30 and a twelve month high of $281.70. The firm has a fifty day moving average of $262.20 and a 200-day moving average of $260.38.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the business posted $2.02 EPS. Equities analysts predict that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on DHR shares. KeyCorp boosted their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. UBS Group lowered their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Finally, Stifel Nicolaus upped their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.